Please provide your email address to receive an email when new articles are posted on . The FDA has approved a new indication for a vascular closure device that ...
Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better ...
Medtronic's ($MDT) Covidien was hit with a recall of 1,661 units of its VenaSeal Sapheon Closure System, a procedural delivery system for an adhesive that treats ...
Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...
BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...
CHICAGO, IL–Use of a large-bore vascular closure device tested in patients undergoing transcatheter aortic valve replacement and endovascular aortic repair procedures appears to be safe and effective ...
Haemonetics Corporation HAE recently gained CE mark certification for the VASCADE vascular closure and VASCADE MVP venous vascular closure systems. The VASCADE system is intended for ‘small-bore’ ...
The AMBULATE Same-Day Discharge Clinical Study Series demonstrates safe and effective use of VASCADE MVP in three studies to date, with more than 800 AF ablation patients discharged the same calendar ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL™ ...
Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...
PARIS -- A vascular closure device without sutures or collagen plugs may be safer than traditional cut-down or suture-based closure devices, according to the FRONTIER II study. At 12 months, there ...
NEW YORK & MUNICH--(BUSINESS WIRE)--Venock announced today it has successfully completed the demonstration of safety and efficacy of its large bore closure system in animal studies. Venock is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results